Pulmonology Medical News about Sleep Apnea, Obstructive Pulmonary Disease, Chronic Obstructive

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Fixed-pressure nCPAP in patients with obstructive sleep apnea (OSA) syndrome and chronic obstructive pulmonary disease (COPD): a 24-month follow-up study
Sleep and Breathing, 10/02/09

Toraldo DM et al. – In these patients with both severe OSA and mild–to–moderate COPD, arterial blood gasses and MPAP improved and stabilized after 3 months of nCPAP therapy, with the greatest improvements being in ESS score, T 90, and maximal inspiratory force from 3 up to 12 months; these parameters remained stable over the following 12 months. Finally, this data support early treatment with nCPAP in such patients.

<< Previous
Long-term Exposure to Ambient Air Pollution and Risk of...

Next >>
Total healthcare costs in the US for preterm infants with...

Sleep and Sleep Disorders in Chronic Obstructive Pulmonary Disease
Respiration, 11/12/09 Relevance Score: 98%

Qualitative study of pain of patients with chronic obstructive pulmonary disease
Heart & Lung; The Journal of Acute and Critical Care, 10/21/09 Relevance Score: 96%

Increased relative mortality in women with severe oxygen-dependent chronic obstructive pulmonary disease
Chest, 10/07/09 Relevance Score: 94%

Obstructive sleep apnea as a risk factor for coronary events or cardiovascular death
Sleep and Breathing, 10/06/09 Relevance Score: 94%

Increased relative mortality in women with severe oxygen-dependent chronic obstructive pulmonary disease
Chest, 10/05/09 Relevance Score: 94%